1. Branched-Chain Amino Acids Prevent Hepatocarcinogenesis and Prolong Survival of Patients With Cirrhosis 
Takumi Kawaguchi, Koichi Shiraishi, Toshifumi Ito, Kazutomo Suzuki, Chizu Koreeda, Takaaki Ohtake, Motoh Iwasa, Yoshio Tokumoto, Ryujin Endo, Nao–hiro Kawamura, Makoto Shiraki, Daiki Habu, Satoru Tsuruta, Yoshiyuki Miwa, Atsushi Kawaguchi, Tatsuyuki Kakuma, Hironori Sakai, Norifumi Kawada, Tatsunori Hanai, Shin–ichi Takahashi, Akinobu Kato, Morikazu Onji, Yoshiyuki Takei, Yutaka Kohgo, Toshihito Seki, Masaya Tamano, Kazuhiro Katayama, Tetsuya Mine, Michio Sata, Hisataka Moriwaki, Kazuyuki Suzuki 
Clinical Gastroenterology and Hepatology 
Volume 12, Issue 6, Pages e1 (June 2014)
DOI: /j.cgh
Copyright © 2014 AGA Institute Terms and Conditions

2. Figure 1
Cumulative incidences of HCC (red lines) and death (black lines) between BCAA and non-BCAA groups. Solid lines indicate the BCAA group, and dashed lines indicate the non-BCAA group.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

3. Supplementary Figure 1
Study design. A cohort of 299 cirrhotic patients without HCC were enrolled in 2009 and followed up until In the course of the study, 32 patients dropped out, and the remaining 267 patients were analyzed (follow-up rate, 89.3%).
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions